Combination Therapies and Personalized Medicine
Cancer Survival Analysis
Nursing Ethical Principles II
Cancer Therapies
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Updated: May 10, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
Michele Masucci1,2, Jenny Del Villar Pérez2, Pamela Mazzocato2
1Department of Microbiology Tumor and Cell Biology (MTC), Karolinska Institutet, Biomedicum Q8C, Solnavägen 9, 171 65 Solna, Sweden.
个性化癌症医学 (PCM) 面临着由于组织和系统障碍的实施挑战. 克服这些需要多方利益相关者的合作和适应性战略,以有效地融入临床实践.
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: